Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Martel

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The British Journal of Nutrition|August 1, 2007
Dietary long-chain n-3 fatty acids modify blood and cardiac phospholipids and reduce protein kinase-C-delta and protein kinase-C-epsilon translocationSébastien Judé, Eric Martel, Fanny Vincent, et al.
Journal of Pharmacological and Toxicological Methods|May 22, 2024
Improving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessmentTodd A Wisialowski, Nick Ether, C Michael Foley, et al.
Molecular Metabolism|July 6, 2025
Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutideRobert Augustin, Anouk Oldenburger, Tamara Baader-Pagler, et al.
Stem Cells Translational Medicine|May 1, 2019
Design and Validation of an Automated Process for the Expansion of Peripheral Blood-Derived CD34<sup>+</sup> Cells for Clinical Use After Myocardial InfarctionClaire Saucourt, Sandrine Vogt, Amandine Merlin, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry PerspectiveHugo M Vargas, Michael G Rolf, Todd A Wisialowski, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The British Journal of Nutrition|August 1, 2007
Dietary long-chain n-3 fatty acids modify blood and cardiac phospholipids and reduce protein kinase-C-delta and protein kinase-C-epsilon translocationSébastien Judé, Eric Martel, Fanny Vincent, et al.
Journal of Pharmacological and Toxicological Methods|May 22, 2024
Improving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessmentTodd A Wisialowski, Nick Ether, C Michael Foley, et al.
Molecular Metabolism|July 6, 2025
Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutideRobert Augustin, Anouk Oldenburger, Tamara Baader-Pagler, et al.
Stem Cells Translational Medicine|May 1, 2019
Design and Validation of an Automated Process for the Expansion of Peripheral Blood-Derived CD34<sup>+</sup> Cells for Clinical Use After Myocardial InfarctionClaire Saucourt, Sandrine Vogt, Amandine Merlin, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry PerspectiveHugo M Vargas, Michael G Rolf, Todd A Wisialowski, et al.
Pageof 3